Page 72 - The lraternational Journal of the Royal Society of Thailand.indd

The International Journal of the Royal Society of Thailand
Volume XV-2023

Reuters. GSK beats expectations, shingles vaccine bolsters outlook. 2023. https://
wwwreuterscom/business/healthcare-pharmaceuticals/gsk-reports-q4-
profit-sales- beat-wall-street-estimates-2023-02-01/.

RTSS_Clinical_Trials_Partnership. Efficacy and safety of RTS,S/AS01 malaria vaccine
with or without a booster dose in infants and children in Africa: final results of

a phase 3, individually randomised, controlled trial. Lancet 2015; 386: 31-45.
RTSS_Clinical_Trials_Partnership. Efficacy and safety of the RTS,S/AS01 malaria

vaccine during 18 months after vaccination: a phase 3 randomized, controlled
trial in children and young infants at 11 African sites. PLoS Med 2014; 11:
e1001685.

TDR. Implementation strategies for delivering the RTS,S/AS01 malaria vaccine in
countries with seasonal transmission. 2023. https://tdrwhoint/newsroom/news/

item/25-04-2023- implementation-strategies-for-delivering-the-rts-s-as01-
malaria-vaccine-in-countries- with-seasonal-transmission.

The_Times_of_India. Covishield production capacity 250-275 million doses a month.
2021. https://timesofindiaindiatimescom/india/covishield-production-
capacity-250-275-million- doses-a-month-covaxin-50-60-million-govt/article-

show/88278989cms.

University_of_Oxford. Oxford R21/Matrix-M™ malaria vaccine receives regulatory
clearance for use in Burkina Faso. 2023. https://wwwoxacuk/news/2023-07-24-
oxford-r21matrix- m-malaria-vaccine-receives-regulatory-clearance-use-burkina-
faso.

Valea I, Adjei S, Usuf E, Traore O, Ansong D, Tinto H, et al. Long-term immunogenic-
ity and immune memory response to the hepatitis B antigen in the RTS,S/AS01(E)
malaria vaccine in African children: a randomized trial. Hum Vaccin Immuno-
ther 2020; 16: 1464-1470.

WHO. Full Evidence Report on the RTS,S/AS01 Malaria Vaccine. 2021. https://cdnwhoint/

media/docs/default-source/immunization/mvip/full-evidence-report-on- the-
rtss-as01-malaria-vaccine-for-sage-mpag-(sept2021)pdf?sfvrsn=c9737be_5.

WHO. COVID-19 vaccine tracker and landscape. 2023. https://wwwwhoint/publica-
tions/m/item/draft-landscape-of-covid-19-candidate-vaccines.

WHO. Malaria vaccine: WHO position paper – January 2016. Weekly Epidemiological
Record 2016; 91: 33-52.

64 The First Licensed Malaria Vaccines: From RTS,S to R21